How Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?
Author(s) -
Hanno Ehlken,
Christoph Schramm
Publication year - 2015
Publication title -
visceral medicine
Language(s) - English
Resource type - Journals
eISSN - 2297-475X
pISSN - 2297-4725
DOI - 10.1159/000431350
Subject(s) - primary sclerosing cholangitis , medicine , malignancy , gastroenterology , context (archaeology) , colorectal cancer , cancer , disease , paleontology , biology
Primary sclerosing cholangitis (PSC) is a chronic inflammatory disease affecting the intra- and extrahepatic bile duct system that can ultimately cause liver cirrhosis. Apart from the risk of progression to end-stage liver disease the prognosis of PSC is primarily determined by the risk to develop hepatobiliary or extrahepatic malignancies. A reasonable surveillance strategy for PSC patients must allow the detection of early cancer that will permit a potentially curative therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom